Important Notice Regarding Oxervate

Posted in Latest News on January 24, 2020.

During the January 17, 2020 Board of Optometry meeting, the Board approved Oxervate (Cenergermin-bkbj) 0.002% for addition to Rule 64B13-18.002, Florida Administrative Code – Formulary of Topical Pharmaceutical Agents.

Important Note: At this time, Oxervate cannot be prescribed by Certified Optometrists in Florida until the rule has been approved. Once the rule has gone through the approval process, notice will be provided on the board website and both may be prescribed by Certified Optometrists at that time.



More Latest News

Third Quarter Performance Report
June 14, 2022

Released for the
2021 – 2022 Fiscal Year Continue reading


Topical Ocular Pharmaceutical Agents added to Formulary
May 27, 2022

The Board of Optometry has added the following Topical Ocular Pharmaceutical Agents to the formulary… Continue reading